M. ESSIZ
Impact in
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
- Organic Chemistry top 10%
- Synthesis and Biological Evaluation
- Asymmetric Synthesis and Catalysis
- Synthesis and biological activity
- Synthesis and Catalytic Reactions
Papers in
-
- Synthesis and Reactions of Organic Compounds 8
- Synthesis and Biological Evaluation 7
- Cyclization and Aryne Chemistry 4
- Synthesis and biological activity 4
- Synthesis and Reactivity of Heterocycles 2
- Synthesis of heterocyclic compounds 2
- Synthesis and pharmacology of benzodiazepine derivatives 2
-
- Cancer therapeutics and mechanisms 5
- Co-authors
- D. Bouzard (13 shared papers)P. Remuzon (10 shared papers)P. DI CESARE (8 shared papers)N. Moreau (1 shared paper)J Fung-Tomc (4 shared papers)Pascale Moreau (1 shared paper)Jean‐Yves Mérour (1 shared paper)Taikan Oki (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (5 papers)Tetrahedron Letters (3 papers)Tetrahedron (2 papers)Antimicrobial Agents and Chemotherapy (1 paper)Drugs (1 paper)
- Partner nations
- FranceGermanyUnited States
In The Last Decade
M. ESSIZ
18 papers receiving 342 citations
Peers
Comparison fields: 5 of 54
- Molecular Medicine 59
- Organic Chemistry 246
- Pharmacology 104
- Toxicology 14
- Pharmaceutical Science 18
Countries citing papers authored by M. ESSIZ
This map shows the geographic impact of M. ESSIZ's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. ESSIZ with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. ESSIZ more than expected).
Fields of papers citing papers by M. ESSIZ
This network shows the impact of papers produced by M. ESSIZ. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. ESSIZ. The network helps show where M. ESSIZ may publish in the future.
Co-authors
The 19 scholars most cited alongside M. ESSIZ, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 72 | |
| 2 | 1990 | 71 | |
| 3 | 1992 | 61 | |
| 4 | 1989 | 39 | |
| 5 | 1997 | 36 | |
| 6 | 1991 | 26 | |
| 7 | 1992 | 20 | |
| 8 | 1980 | 14 | |
| 9 | 1995 | 10 | |
| 10 | 1976 | 6 | |
| 11 | 1974 | 6 | |
| 12 | 1992 | 5 | |
| 13 | 1988 | 5 | |
| 14 | 1993 | 3 | |
| 15 | 1979 | 3 | |
| 16 | 1989 | 2 | |
| 17 | 1993 | 1 | |
| 18 | 1979 | 1 |
About M. ESSIZ
M. ESSIZ is a scholar working on Organic Chemistry, Molecular Biology, Pharmacology, Infectious Diseases and Oncology, having authored 18 papers that have together received 381 indexed citations. Recurring topics across this work include Synthesis and Reactions of Organic Compounds (8 papers), Synthesis and Biological Evaluation (7 papers), Cancer therapeutics and mechanisms (5 papers), Cyclization and Aryne Chemistry (4 papers), Synthesis and biological activity (4 papers), Synthesis and Reactivity of Heterocycles (2 papers), Synthesis of heterocyclic compounds (2 papers) and Synthesis and pharmacology of benzodiazepine derivatives (2 papers). The work is most often cited by research in Molecular Medicine (59 citations), Organic Chemistry (246 citations), Pharmacology (104 citations), Toxicology (14 citations) and Pharmaceutical Science (18 citations). M. ESSIZ has collaborated with scholars based in France, Germany and United States. Frequent co-authors include D. Bouzard, P. Remuzon, P. DI CESARE, N. Moreau, J Fung-Tomc, Pascale Moreau, Jean‐Yves Mérour, Taikan Oki, P. Caubère and J.R. Kiechel. Their work appears in journals such as Journal of Medicinal Chemistry, Tetrahedron Letters, Tetrahedron, Antimicrobial Agents and Chemotherapy and Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.